Profile
← Back to the index
Gunasekaran (Guna) Kannan
Founder & Chief Scientific Officer · BraneX | Series A–Funded | Next-Gen Therapeutic Platform
United States
Details
- Industry
- Internet Services
- Indian undergraduate
- Not provided
- Highest education
- PhD, Indian Institute of Science (IISc)
- Company size
- Not provided
- Role type
- Founder
Company
BraneX | Series A–Funded | Next-Gen Therapeutic Platform
BraneX is a Series A–funded biotechnology company developing a next‑generation therapeutic platform that engineers and delivers mRNA‑encoded and protein‑based biologics (including multispecifics and advanced delivery systems) to create novel treatments across oncology, inflammation, metabolic and neurological indications; its target audience includes biopharmaceutical partners, translational researchers, and clinical developers.